To investigate the effect of transcription-modulating drugs, fenofibrate and isotretinoin, on metabolic profile, insulin sensitivity of adipose and muscle tissues and gene expression in a genetic model of insulin resistance syndrome, polydactylous rat strain (PD/Cub). DESIGN: Administration of fenofibrate (100 mg/kg/day), isotretinoin (30 mg/kg/day) or vehicle to adult male PD/Cub rats fed standard laboratory chow for 15 days. MEASUREMENTS: Parameters of lipid and carbohydrate metabolismForal glucose tolerance test, serum concentrations of insulin, triglycerides (TG), free fatty acids (FFA), glycerol, total cholesterol (CH); morphometric variables, in vitro insulin sensitivity of adipose and muscle tissues, catecholamine-stimulated lipolysis and the expression of ApoC-III and Hnf-4 genes in liver. RESULTS: Both experimental groups displayed an increase in adiposity with contrasting effects on TG (lowered by fenofibrate and increased by isotretinoin) and gene expression (no change in fibrate-treated rats and increased expression of ApoC-III and Hnf-4 in isotretinoin-treated group). Fenofibrate-treated rats also showed decreased concentrations of FFA and CH with concomitant decrease of catecholamine-induced lipolysis in adipocytes, but also hyperinsulinemia and the highest insulin/ glucose ratio. Isotretinoin increased glycerol concentrations and decreased the insulin sensitivity of peripheral tissues. CONCLUSION: The PD/Cub rat showed a distinct pharmacogenetic reaction to fenofibrate and isotretinoin administration. Several lines of evidence now implicate specific variant(s) of ApoC-III and/or ApoA-V alleles as responsible for the dyslipidemia observed in this genetic model. The PD/Cub strain may also serve as a pharmacogenetic model for dissection of the retinoidinduced hypertriglyceridemia.
Introduction
Hypertriglyceridemia represents a frequent metabolic alteration and has been identified as a major independent risk factor of coronary heart disease. 1, 2 The elevated levels of triglycerides (TG) are often found as a part of a wider metabolic derangement, such as metabolic (or insulin resistance) syndrome. The resulting level of TG in plasma represents a state of dynamic equilibrium with multiple components of influence. It is clearly established that there is a substantial involvement of genetic factors; 3 however, the exact underlying mechanisms are yet to be elucidated. The pharmacological modulation of the triglyceride concentrations occurs either as their therapeutic lowering in dyslipidemias (eg by fibrates 4 ), or as their elevation as a side effect of administration of certain medications (eg retinoids 5 ). Both fibratesFagonists of peroxisome proliferator-activated receptor alpha (PPARa)Fand retinoidsFpanagonists of the retinoic acid receptors RAR and RXRFwere commonly shown to influence triglyceridemia through changing the expression of apolipoprotein C-III (ApoC-III) gene. 6, 7 This gene alone as well as the whole ApoA-I/C-III/A-IV cluster (and most recently its new member, ApoA-V) were associated with dyslipidemia in human populations and animal models 3, 8 and were also suggested as putative candidates for hypertriglyceridemia in a genetic model of insulin resistance syndrome, polydactylous (PD/Cub) rat strain [9] [10] [11] [12] [13] [14] (http:// www.img.cas.cz/fb/, Table 1 ). Therefore, we examined the effect of fenofibrate and isotretinoin administration on metabolic profile, insulin sensitivity and lipolysis in tissues and the expression of ApoC-III and one of its proposed upstream regulatory genes, hepatocyte nuclear factor-4 (Hnf-4), in the PD/Cub rat strain.
Methods

Animals and experimental protocol
All experiments were performed in agreement with the Animal Protection Law of the Czech Republic (311/1997), which corresponds fully to the European Community Council recommendations for the use of laboratory animals 86/609/ECC. Polydactylous rat strain (PD/Cub) is highly inbred rat strain (F470, verified by several total genome scans) kept since 1969 at Institute of Biology Medical Genetics, First Faculty of Medicine, Charles University, Prague. It originated from Wistar rats exhibiting a spontaneous mutation (Lx) which gave rise to the polydactyly-luxate syndrome. 9 The PD/Cub rat strain has been exploited as a model of limb development and teratology, 9-11 hypertriglyceridemia 10-14 and it was recently established as a model of the insulin resistance syndrome. 13, 15 Adult male PD/Cub rats (18 weeks of age) were randomly divided into three groups. All groups were provided with standard laboratory chow and drinking water ad libitum. The two experimental groups received either fenofibrate (100 mg/kg/day; n ¼ 6) or isotretinoin (Roaccutane s , 30 mg/kg/day; n ¼ 5) in soya oil vehicle (0.25 ml) via oral gavage. The third, control group (n ¼ 4) received only vehicle via oral gavage. The treatment lasted for 15 days. Body weights were measured throughout the treatment period. Blood samples from the tail vein were collected between 0800 and 0900 in nonfasted animals. In the end of experiment, animals were killed and tissues were collected and weighed.
Metabolic measurements
The oral glucose tolerance test (OGTT) was performed after overnight fasting. Blood for glycemia determination was drawn from the tail vein at intervals of 0, 30, 60 and 120 min after the intragastric glucose administration to conscious rats (3 g/kg total body weight, 30% aqueous solution). Commercially available analytical kits were employed to determine plasma glucose, cholesterol, serum triglyceride (TG) concentrations (Pliva-Lachema, Brno, Czech Republic) and glycerol (Sigma, USA). Serum free fatty acids (FFA) concentrations were determined using an acyl-CoA oxidase-based colorimetric kit (Roche Diagnostics GmbH, Mannheim, Germany). Serum insulin concentration was determined using RIA kit for rat insulin assay (Amersham Pharmacia Biotech UK Ltd., Little Chalfont, UK).
Basal and insulin-stimulated incorporation of D-[U- 14 C] glucose into total lipids (lipogenesis) of rat adipose tissue and into glycogen of adipose tissue and skeletal muscle (glycogenesis) in vitro was determined. In short, after decapitation, distal parts of the epididymal adipose tissue (200 mg) or hemidiaphragms were incubated in Krebs-Ringer bicarbonate buffer containing half of the recommended amount of calcium at 371C, gas phase 95% O 2 þ 5% CO 2 , pH 7.4 that contained 5.5 mM unlabeled glucose, 0.1 mCi/ml of D-[U-
14
C] glucose, and 3 mg/ml fatty acid and insulin-free BSA (Armour, Fraction V) with or without 250 mU/ml insulin. After incubation (120 min), the adipose tissue lipids were extracted according to Folch et al 16 and the radioactivity was determined as described previously. 17 The glycogen from hemidiaphragm and from delipided adipose tissue was extracted by boiling in 30% KOH, reprecipitated three times with 60% ethanol, and after dissolving in water the radioactivity was determined as described previously. 17 For assessment of the lipolysis, the distal parts of adipose tissue were incubated in Krebs-Ringer phosphate buffer containing 3% bovine serum albumin (Armour, Fraction V) at 371C, pH 7.4 with or without epinephrine (0.25 mg/ml). The tissue was incubated for 2 h and the concentrations of FFA and glycerol in the medium were determined. We have chosen to use adipose tissue instead of isolated adipocytes because we have repeatedly not been observing substantially different results of catecholamine-stimulated lipolysis and D-[U-
14 C] glucose incorporation between experiments with isolated adipocytes and the adipose tissue. Furthermore, distal part of the epididymal adipose tissue is very thin allowing the substrate to penetrate the tissue readily. On the other hand, larger adipocytes are more fragile and tend to break more often during extraction than the smaller adipocytes, and due to the different metabolic profile Isotretinoin and fenofibrate induce adiposity L Sedova et al of the two adipocyte classes a shift in the resulting measurements may occur. Also, the protease content of collagenase used for digestion may lead to disruption of the membrane receptors. Collagenase digestion has been reported to alter, for example, the adenylate cyclase/cyclic AMP stimulatory pathway. 18 And finally, it is well established that adenosine, leaking out from isolated adipocytes, is involved in the inhibition of fat cell lipolysis. 19 Results from multiple sources show that addition of the adenosine deaminase to the medium increases the basal, but not the stimulated lipolysis. 20 Interestingly, addition of adenosine deaminase was also found not to reduce variability of catecholamine stimulated lipolysis. 21 As we did not choose to use the isolated adipocytes, we decided not to add adenosine deaminase into the medium.
Semiquantitative RT-PCR Total RNA was isolated from the liver by the acid guanidinium thiocyanate-phenol-chloroform method using an RNA extraction solution (TRIZOL Reagent, Sigma, USA).
RT-PCR was carried out using RT-PCR kit (Sigma, USA) according to the manafacturer's instructions. The singlestranded cDNA products were subjected to PCR, the products were electrophoresed on a 6% polyacrylamide gel, stained with ethidium bromide and quantified by densitometoric analysis using the GS-710 Calibrated Imaging Densitometer (Bio-Rad, USA) with the Quantity One Software (Bio-Rad, USA). Care was taken to quantify changes in individual mRNA levels by determining (for each primer pair) and employing appropriate RT-PCR conditions under which a linear relationship existed between amounts of RNA added and intensities of the RT-PCR products. The expression levels of ApoC-III and Hnf-4 were calculated as relative to the expression of the control, house-keeping acidic ribosomal phosphoprotein 1 (Arp-1) gene. The primers used were:
0 .
Statistical analysis
The data were analyzed by one-way ANOVA followed by post hoc (Tukey's) test. Null hypothesis was rejected whenever Po0.05.
Results
Effect on organ weight and adiposity
The total body weight of the three groups did not differ before the experimental protocol, 1 week into the experiment and in the end of experiment. The pattern of weight gain followed a similar pattern in all three groups. However, administration of both substances significantly increased the adiposity index (Table 2) , calculated as epididymal fat pad weight/100 g total body weight. Fenofibrate, but not isotretinoin, also increased the relative weights of liver (Po0.001 vs control) and kidneys (P ¼ 0.004 vs control). The relative heart weight did not differ among the three groups.
Lipid profile
Both fenofibrate-and isotretinoin-treated groups showed significant and opposite changes in TG levels (both fasting and postprandial), which were apparent already after 1 week of the treatment (controls 1.9770.11, isotretinoin group 2.9670.13 and fenofibrate group 0.9970.08 mmol/l, ANO-VA Po0.0001) and were still present at the end of experi- Isotretinoin and fenofibrate induce adiposity L Sedova et al ment ( Table 2 ). The fed concentrations of serum total cholesterol and FFA were lowered by fenofibrate treatment (Po0.001 and P ¼ 0.004 vs control, respectively), while isotretinoin administration did not result in any changes. Serum glycerol (fed) was higher in the isotretinoin-treated group compared to the control and fenofibrate-treated groups (P ¼ 0.031 and 0.002, respectively).
OGTT and insulin
As glycemia (in fed animals) was not affected by either treatment and insulin level (fed) was significantly higher in the fenofibrate-treated rats, the insulin/glucose ratio was significantly higher in this group (0.07970.012 vs 0.03370.004 in control, P ¼ 0.003). The glucose levels at 30 and 120 min after the glucose load and the area over the curve of the OGTT were significantly highest in the fenofibrate-treated group (Figure 1 ). Isotretinoin and fenofibrate induce adiposity L Sedova et al
Lipolysis and insulin sensitivity of the adipose tissue
Insulin sensitivity of the skeletal muscle (diaphragm)
The basal incorporation of D-[U-14 C] glucose into glycogen of the hemidiaphragm was not significantly different in isotretinoin-treated vs control rats, the insulin-stimulated values were only marginally lower. Overall, the isotretinoin treatment aggravated the insulin resistance in the diaphragm muscle, while the fenofibrate slightly improved it, increasing the basal incorporation of labeled glucose and not changing significantly the insulin-induced increase (Figure 2d ).
Expression of ApoC-III and Hnf-4
The expression levels of the ApoC-III and Hnf-4 followed similar pattern, the significantly highest levels were reached in the isotretinoin-treated group (Po0.001 vs control) and no effect was observed in the fibrate-treated group (Figure 3) . The same was true for the expression of retinoic acid receptor-alpha in liver (data not shown).
Discussion
The polydactylous rat strain PD/Cub has been recently established as a genetic model of the insulin resistance syndrome. 13 The genetic architecture of this complex trait in the PD/Cub rat is currently being investigated 15, 22 and it is clear that the strain displays a specific pharmacogenetic profile upon administration of drugs affecting the features of the metabolic syndrome. 23 This study shows the PD/Cub strain to be sensitive to modulation of triglyceride concentrations by isotretinoin, a phenomenon previously noted not only as a side effect of the treatment aimed at mostly dermatological disorders, 5 but also as a possible pharmacogenetic indicator of hereditary proneness to familial combined hyperlipidemia and metabolic syndrome. 24 Moreover, the increased adiposity and insulin resistance of skeletal muscle tissue in the isotretinoin-treated group are well in consent with the adverse reactions seen in the sensitive human subjects. 24 Therefore, this strain may well serve as a tool for dissection of the genetic component involved in the described pharmacogenetic interaction. The mechanism of retinoic acid induced hypertriglyceridemia is unknown. VuDac et al 7 demonstrated that retinoids increase plasma triglyceride concentration, at least in part, by stimulating ApoCIII gene expression at the transcriptional level via a RXR-mediated mechanism. On the other hand, there is a fair amount of evidence that RXR-specific agonists (rexinoids) can improve glucose tolerance and decrease hyperglycemia, hypertriglyceridemia and hyperinsulinemia. 25 Though our results do not provide evidence for a causal link and the subtype of retinoid receptor involved, the increased expression of Hnf-4 and ApoC-III coincided with an elevation of triglyceride and glycerol levels in the PD/Cub rats, suggesting a possible mechanism for the observed metabolic effect. Furthermore, the increased availability of circulating glycerol, a substrate for liver gluconeogenesis and alpha-glycerolphosphate synthesis, together with unchanged FFA may contribute to the hepatic triglyceride synthesis in the isotretinoin-treated group. The triglyceride-lowering effect of fibrates has been mainly attributed to an inhibition of the synthesis and secretion of TG by the liver and their increased clearance from the circulation. 26 In the PD/Cub rat, the decrease in plasma TG induced by the fenofibrate was, unexpectedly, not accompanied by a change in ApoC-III (or Hnf-4) expression, a phenomenon thought to be responsible, together with stimulation of expression of lipoprotein lipase, 27 for PPARadriven changes of handling of TG-rich particles in plasma. 6 This effect, together with a rather significant rise in the overall glucose intolerance and insulinemia, may suggest a presence of a pharmacogenetic interaction involving a distinct ApoC-III allele, similarly reported by others (eg Waterworth et al 28, 29 ). This notion is further supported by the results of metabolic profiling of BN-Lx congenic strain, which carries a segment of chromosome 8 including the ApoAI/C-III/A-IV/A-V cluster of PD/Cub origin on the Brown Norway genetic background and shows significant altera- 38 This fact further underlines the specific allelic combination present in the PD/Cub rat strain and provides an example of usefulness of defined genetic modelsFwhen exposed to similar conditions, the responses specifically elicited in a particular strain facilitate the identification of the causal allelic variant.
As Hnf-4 is just one of the proposed mediators of fenofibrate action on ApoC-III expression, 30 the absence of change in Hnf-4 expression does not necessarily indicate the presence of a defect upstream of the ApoC-III. However, in the light of recent identification of the novel apolipoprotein A-V as a major determinant of triglyceridemia in men, mice and rats 31, 32 and with the recent proof of its direct high responsiveness to fenofibrate, 33 it is also possible that the observed hypolipidemic effect was mediated by ApoA-V, however, a direct proof would be needed. Interestingly, Vrana et al 34 reported a hypotriglyceridemic effect of another fibrate, gemfibrozil, which was not associated with muscle fatty acid and glucose oxidation nor with LPL activity in Wistar male rats. Considering the subtle improvement of insulin resistance in adipose and muscle tissues by fenofibrate and the observed liver enlargement (possibly due to the peroxisome proliferation 35 ), our results point to this organ as a possible pathophysiological site for the derangements in carbohydrate metabolism. In summary, we report a complex metabolic reaction of the PD/Cub rat to isotretinoin and fenofibrate administration, which qualifies this inbred strain as a valuable model for dissection of pharmacogenetic interactions.
